[Opipramol (Insidon) in the treatment of somatoform disorders]

Fortschr Neurol Psychiatr. 1998 Dec:66 Suppl 1:S25-30. doi: 10.1055/s-2007-1001161.

[Article in French]

Authors

H J Freyberger¹, H J Grabe, W Maier, A Janca, K D Stoll

Affiliation

¹ Klinik und Poliklinik für Psychiatrie und Psychotherapie, Ernst-Moritz-Arndt-Universität Greifswald im Klinikum der Hansestadt Stralsund.

PMID: 9922924
DOI: 10.1055/s-2007-1001161

No abstract available

Publication types

Clinical Trial
Randomized Controlled Trial

MeSH terms

Antidepressive Agents, Tricyclic / administration & dosage
Antidepressive Agents, Tricyclic / adverse effects
Antidepressive Agents, Tricyclic / therapeutic use*
Anxiety / drug therapy
Anxiety / psychology
Delayed-Action Preparations
Female
Humans
Male
Middle Aged
Opipramol / administration & dosage
Opipramol / adverse effects
Opipramol / therapeutic use*
Psychiatric Status Rating Scales
Somatoform Disorders / drug therapy*
Somatoform Disorders / psychology

Substances

Antidepressive Agents, Tricyclic
Delayed-Action Preparations
Opipramol